Immediate Impact

1 by Nobel laureates 2 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
5 intermediate papers

Works of Jane E. Brock being referenced

Effect of cabozantinib treatment on circulating immune cell populations in patients with metastatic triple-negative breast cancer (TNBC).
2016
Interobserver Concordance in Implementing the 2010 ASCO/CAP Recommendations for Reporting ER in Breast Carcinomas
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Jane E. Brock 360 306 215 42 703
Penny J. Barnes 333 261 225 44 823
Sandra S. Hatch 311 369 216 53 798
Elizabeth Salisbury 232 355 301 39 799
R. Knight 364 270 115 32 634
Shunsuke Haga 213 232 181 80 630
J.A. van Dongen 405 419 269 35 836
Gerson Lesnick 391 323 166 22 722
Tsunehiro Ishida 350 170 107 52 634
Speer Fd 307 214 154 27 757
Sven‐Börje Ewers 339 287 149 27 748

All Works

Loading papers...

Rankless by CCL
2026